Advertisement
Podcast

Jordan Grumet, MD, on Bridging the Intimacy Gap Between Doctor and Patient

10/25/2019

 

In this podcast, Jordan Grumet, MD, talks about his session at this year's Cardiometabolic Risk Summit about how sharing your story with patients via social media and other avenues can help bridge the intimacy gap.

Jordan Grumet, MD, is an internal medicine physician who is currently practicing as a hospice and palliative care physician at Journeycare Hospice. He is also a storyteller who tells stories about medicine online and in various venues, including a personal blog.

Additional Resources:

  • Grumet J. Keynote: Bridging the intimacy gap between doctor and patient through social media and shared storytelling. Talk presented at: Cardiometabolic Risk Summit 2019; October 24-26, 2019; Orlando, FL. https://cdmcd.co/kM4vW.
  • Grumet J. In My Humble Opinion [blog]. Accessed September 12, 2019. https://jordan-inmyhumbleopinion.blogspot.com.

Related Content

dairy consumption
dairy consumption
Dairy and Early Menopause: Is There a Connection?
03/02/2022
Alexandra Purdue-Smithe, PhD, from the National Institutes of Health, shares her insights on her latest research, which found that certain dairy foods may be tied to the risk of early menopause in...
03/02/2022
Migraine
Migraine
Kathleen Digre, MD, on The Role of Eye Pain and Photophobia in Migraine, Dry Eyes, and More
02/16/2022
In this podcast, Dr Digre discusses the association of photophobia and eye pain with migraine, dry eyes, and related conditions, as well as common pitfalls in the management and treatment of photophobia and...
02/16/2022
research
research
Jeffrey Tabas, MD, on New Research for Atrial Fibrillation
02/21/2022
In this podcast, Jeffrey Tabas, MD, shares his thoughts on the next steps for research on atrial fibrillation, including the types of studies still needed.
02/21/2022
HIV Infection
HIV Infection
Sadeer Al-Kindi, MD, on HF Rehospitalizations in People With HIV
11/21/2019
He discusses his new research that identified the risk of heart failure rehospitalization among people with and without HIV who have heart failure.
11/21/2019
Cardiovascular Diseases
Cardiovascular Diseases
Thomas Seck, MD, on the EMPA-REG OUTCOME Trial: Empagliflozin Reduces CV Risk by 38%
10/09/2017
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
10/09/2017